SEATTLE GENETICS INC - COM (SGEN) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2023

Type / Class
Equity / COM
Symbol
SGEN
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q4 0 $0 -$5,286,595 0
2023 Q3 24,919 $5,286,595 -$3,059,634 $212.15 3
2023 Q2 41,477 $7,982,969 +$3,024,430 $192.46 4
2023 Q1 25,764 $5,216,437 -$5,677,700 $202.47 2
2022 Q4 69,945 $8,988,631 -$4,744,846 $128.51 4
2022 Q3 106,867 $14,622,000 -$3,543,163 $136.83 3
2022 Q2 129,755 $22,959,000 -$7,548,748 $176.95 3
2022 Q1 172,563 $24,839,000 +$4,243,764 $144.02 4
2021 Q4 142,904 $22,069,006 -$6,214,401 $154.55 5
2021 Q3 179,050 $30,434,000 -$3,795,814 $169.81 9
2021 Q2 197,942 $31,250,000 +$4,796,974 $157.86 6
2021 Q1 167,769 $23,296,000 -$84,897,861 $138.87 8
2020 Q4 655,594 $114,820,000 -$20,749,012,541 $175.14 17
2020 Q3 107,006,728 $20,903,721,082 -$9,082,051,270 $195.69 388
2020 Q2 160,907,362 $27,326,078,670 -$558,523,455 $169.92 484
2020 Q1 164,748,250 $19,004,617,171 +$177,933,009 $115.38 380
2019 Q4 163,205,704 $18,645,276,325 -$337,808,298 $114.26 388
2019 Q3 165,320,231 $14,110,723,053 +$497,079,069 $85.40 317
2019 Q2 160,955,072 $11,136,717,667 -$19,298,142 $69.21 317
2019 Q1 161,967,217 $11,861,268,308 -$114,684,352 $73.24 335
2018 Q4 163,694,210 $9,274,001,669 +$7,094,549 $56.66 294
2018 Q3 163,166,313 $12,583,486,736 -$126,922,552 $77.12 320
2018 Q2 165,150,062 $10,963,789,253 -$317,143 $66.39 288
2018 Q1 165,565,585 $8,665,636,727 +$990,377,878 $52.34 279
2017 Q4 147,155,743 $7,872,607,446 +$190,208,976 $53.50 291
2017 Q3 143,603,750 $7,812,893,457 +$135,085,946 $54.41 264
2017 Q2 140,020,768 $7,245,166,952 -$20,654,529 $51.74 298
2017 Q1 140,638,669 $8,842,445,745 +$607,307,932 $62.86 294
2016 Q4 137,892,346 $7,277,629,308 -$74,014,437 $52.77 260
2016 Q3 139,343,175 $7,524,385,677 +$53,276,367 $54.01 237
2016 Q2 138,409,848 $5,593,277,935 -$113,465,524 $40.41 206
2016 Q1 141,464,114 $4,959,329,730 -$11,283,389 $35.09 189
2015 Q4 140,882,514 $6,322,895,605 -$49,528,290 $44.88 228
2015 Q3 141,880,302 $5,470,870,535 +$552,749,144 $38.56 220
2015 Q2 127,586,122 $6,174,629,272 +$58,671,701 $48.40 218
2015 Q1 126,541,743 $4,472,505,407 -$69,044,069 $35.35 199
2014 Q4 128,674,429 $4,134,575,396 +$81,176,976 $32.13 211
2014 Q3 125,306,397 $4,658,728,788 -$63,512,854 $37.18 192
2014 Q2 126,867,809 $4,852,685,300 -$35,639,853 $38.25 194
2014 Q1 127,439,612 $5,804,946,729 +$68,509,338 $45.56 206